Language: BG BG
← Back to results
Recruiting NCT06587100

Wearable Activity Tracking to Curb Hospitalizations

Conditions: Hematopoietic Neoplasm Malignant Solid Neoplasm Lymphatic System Neoplasm

Sponsor: University of California, San Francisco

trial.available_in: БГ
Overview
This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.
Description
PRIMARY OBJECTIVE: I. Validate a previously developed step-count model for predicting all-cause acute care (pooled across all devices). SECONDARY OBJECTIVES: I. Validate a previously developed model for predicting each ED visits or hospitalizations during external beam RT using continuous step counts before, during, and after treatment. II. Validate the previously developed step-count model for predicting all-cause acute care for each of the two different device platforms. III. Validate concordance of step counts across each of the device's platforms in the Apple group. IV. Validate the previously developed SHIELD-RT Electronic health record (EHR)-based model for predicting unplanned acute care (ED visit or hospitalization). EXPLORATORY OBJECTIVES: I. Refinement of the pre-existing models(step count and SHIELD-RT). II. Evaluate association between wearables collected parameters, EHR-based variables, and acute care events. III. Develop and validate a multi-modal predictive model for predicting acute care. OUTLINE: This is an observational study. Participants are assigned to 1 of 2 groups. * GROUP I: Participants receive Fitbit device and undergo non-interventional, standard of care, radiation therapy. * GROUP II: Participants receive Fitbit device and utilize their own personal Apple HealthKit-based device and undergo non-interventional, standard of care, radiation therapy.
Who can participate
Inclusion Criteria: * Age \>= 18. * Eastern Cooperative Oncology Group (ECOG) performance status =\< 2. * Able to understand study procedures and to comply with them for the entire length of the study. * Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it. * Diagnosis of invasive malignancy. * Able to ambulate independently (without the assistance of a cane or walker). * Planned treatment with fractionated external beam radiotherapy over at least 5 days (no fractional requirement). * Not a previous participant on this protocol for subsequent courses. Exclusion Criteria: * Participants bound to a wheelchair. * Participants unable to ambulate independently (needing assistance of cane or walker).
Interventions
Fitbit
DEVICE
Apple HealthKit-based devices
DEVICE
Locations 1
United States (1)
University of California, San Francisco
San Francisco , California
Technical details
Status
Recruiting
Study type
OBSERVATIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
07.04.2025
Completion date
31.12.2027
Registry ID
NCT06587100
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.